LOS ANGELES, March 1, 2017 – Generated Positive EBITDA in Fourth Quarter 2016 – Full Year 2016 Revenue Increased 162% to $7.1 million – $1.5 million in Deferred Revenue as of Dec. 31, 2016 LOS ANGELES, March 1, 2017, CATS, /PRNewswire/ — Catasys, Inc. (CATS), a provider of proprietary predictive analytics and integrated treatment solutions to health plans, today reported its financial results for the three-month period and full year ended December 31, 2016. “Revenue increased by 200% to $3.8 million for the fourthRead more
- CytoDyn Announces Productive Pre-BLA Meeting with FDA for PRO 140 Combination Therapy
- Maven to Launch Sports Network in Partnership with The Sports Xchange
- Freedom Leaf Enters $20 Billion Anti-Cholesterol Market With Acquisition of a Patent Pending Non-Prescription Formula. No FDA Approval Required. Complimentary Diversification In Health Care
- PotNetwork Holdings, Inc.’s Diamond CBD Continues Surpassing $2 Million In Sales Per Month Practically Doubling Revenues Year Over Year
- Chinese eSports Tournament Group Seeks to Add Cryptocurrency to Their Prize Pools
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More